Patients News | pharmaphorum

News

HCP with a small pile of pills in their palm

NICE relents, ending postcode access to prostate cancer drug

Men in England with high-risk prostate cancer will soon be able to get treatment with a drug available in Scotland and Wales for almost three years.

News

Autonomous AI can spot cognitive decline in medical notes

An AI that screens for early cognitive impairment by sifting through routine clinical documents has shown its value in a real-world evaluation.

News

Trump's affordability plan arrives, built around MFN pricing

Trump has finally delivered his healthcare proposals, but it seems the 'concept of a plan' promised for many years remains pretty much just that.

News

A globe atlas from above on a white surface

Novartis issues a life sciences warning in a 'G-Zero' world

Novartis claims life sciences lie at the centre of a shift in geopolitics and policies in regions like Europe, Japan, and Canada are "self-defeating."

News

FDA seeks changes to GLP-1, flu shot labels

The FDA has asked manufacturers of GLP-1 drugs used for weight loss to remove warnings of suicidal thinking, but added warnings to flu shots.

News

JPM: Anthropic reveals its answer to ChatGPT for Health

Anthropic has launched Claude for Healthcare, a suite of AI tools designed for health systems, payers, and patients.

NICE relents, ending postcode access to prostate cancer drug

Autonomous AI can spot cognitive decline in medical notes

Trump's affordability plan arrives, built around MFN pricing

Novartis issues a life sciences warning in a 'G-Zero' world

FDA seeks changes to GLP-1, flu shot labels

JPM: Anthropic reveals its answer to ChatGPT for Health

Lilly partners with Hims & Hers on obesity drug sales

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks